🎁 💸 Warren Buffett's Top Picks Are Up +49.1%. Copy Them to Your Watchlist – For FreeCopy Portfolio

UPDATE 1-Australia's I-MED plans $360 mln IPO, hires Goldman, Macquarie -source

Published 25/08/2015, 01:55 pm
UPDATE 1-Australia's I-MED plans $360 mln IPO, hires Goldman, Macquarie -source
GS
-
MQG
-
HSO
-
MPL
-

* Australian IPO market is down 59 pct in H1 2015

* Listing would rank among Australia's top 5 of the year

* Signals return to health sector listings (Recasts with IPO market context, timing of sale)

By Byron Kaye

SYDNEY, Aug 25 (Reuters) - I-MED Radiology Network, Australia's biggest medical imaging firm, plans to raise A$500 million ($360 million) in an initial public offering, a source with knowledge of the matter said - a rare sign of life in an extremely weak year for Australian listings.

The planned IPO would likely rank among Australia's top five this year. Concerns about China's economic slowdown, a U.S. interest rate hike and Europe's exposure to Greek debt have hit appetite for new listings.

Sydney-based I-MED has hired Goldman Sachs (NYSE:GS) GS.N and Macquarie Group Ltd MQG.AX to help sell about half of its shares, which would give it a market capitalisation of around A$1 billion, said the source.

The company and its bankers plan to conduct the listing before the end of 2015, the source added, declining to be identified as he was not authorised to speak about the matter to media.

Representatives for I-MED, Goldman and Macquarie were not immediately available for comment.

Some A$2.4 billion of announced Australian IPOs have been cancelled and the value of IPOs for the first half of the year has plunged 59 percent, according to Thomson Reuters data.

The share sale plans, however, underscore the relative strength of Australian health companies after the sector was responsible for more than half of all IPOs in 2014 - a record year for listings.

The company that was responsible for the biggest listing of last year, health insurer Medibank Private Ltd MPL.AX , is trading 14 percent above its issue price following its November debut. The No. 2 listing, hospital company Healthscope Ltd HSO.AX , is trading 21 percent over its issue price.

I-MED has some 200 clinics and conducts 4 million patient procedures a year, according to its website.

($1 = 1.3847 Australian dollars)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.